Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050172-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 6, 2026 |
| Document Date | Jan 2, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
14,532
Total Value
$246,142.01
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D & CMO | Common Stock | โ | Jan 2, 2026 | Exercise/Conversion | 4,432 | $10.42 | $46,181.44 | 4,432 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Jan 2, 2026 | Sale | 4,432 | $40.43 | $179,187.53 | 0 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Jan 5, 2026 | Exercise/Conversion | 412 | $10.42 | $4,293.04 | 412 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Jan 5, 2026 | Sale | 412 | $40.00 | $16,480.00 | 0 | Direct | โ | View Details | |
President, R&D & CMO | Stock Option (Right to Buy) | Derivative | Jan 2, 2026 | Exercise/Conversion | 4,432 | $0.00 | $0.00 | 337,975 | Direct | โ | View Details | |
President, R&D & CMO | Stock Option (Right to Buy) | Derivative | Jan 5, 2026 | Exercise/Conversion | 412 | $0.00 | $0.00 | 337,563 | Direct | โ | View Details |